Gene · 538
Papers3,096
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,096
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Co-Administration of Roxadustat and Zinc Stabilizes Both Serum Copper and Zinc Concentrations in Patients Undergoing Hemodialysis. | Nutrients | 2023 | 38068745 | PubTator, text mining | PubMed |
| Research Progress on the Effects of Support and Support Modification on the FTO Reaction Performance of Fe-Based Catalysts. | Molecules | 2023 | 38067481 | PubTator, text mining | PubMed |
| An association between ATP7B expression and human cancer prognosis and immunotherapy: a pan-cancer perspective. | BMC Med Genomics | 2023 | 38037104 | PubTator, text mining | PubMed |
| Integrated analysis reveals a potential cuproptosis-related ceRNA axis SNHG17/miR-29a-3p/GCSH in prostate adenocarcinoma. | Heliyon | 2023 | 38027603 | PubTator, text mining | PubMed |
| Editorial: Recent advances in the research and development of kinase-inhibitory anticancer molecules. | Front Chem | 2023 | 38025062 | PubTator, text mining | PubMed |
| Cuproptosis: emerging biomarkers and potential therapeutics in cancers. | Front Oncol | 2023 | 38023234 | PubTator, text mining | PubMed |
| Identification of a novel cuproptosis-related gene signature for multiple myeloma diagnosis. | Immun Inflamm Dis | 2023 | 38018590 | PubTator, text mining | PubMed |
| Crosstalk between copper homeostasis and cuproptosis reveals a lncRNA signature to prognosis prediction, immunotherapy personalization, and agent selection for patients with lung adenocarcinoma. | Aging (Albany NY) | 2023 | 38011277 | PubTator, text mining | PubMed |
| Assessment of hypoxia and oxidative-related changes in a lung-derived brain metastasis model by [64Cu][Cu(ATSM)] PET and proteomic studies. | EJNMMI Res | 2023 | 38006431 | PubTator, text mining | PubMed |
| Astrocytes: Lessons Learned from the Cuprizone Model. | Int J Mol Sci | 2023 | 38003609 | PubTator, text mining | PubMed |
| SLC31A1 Identifying a Novel Biomarker with Potential Prognostic and Immunotherapeutic Potential in Pan-Cancer. | Biomedicines | 2023 | 38001885 | PubTator, text mining | PubMed |
| Effects of Everolimus in Modulating the Host Immune Responses against Mycobacterium tuberculosis Infection. | Cells | 2023 | 37998388 | PubTator, text mining | PubMed |
| [Analysis of clinical characteristics and ATP7A gene variants in a Chinese pedigree affected with Menkes disease]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2023 | 37994131 | PubTator, text mining | PubMed |
| Iron and copper: critical executioners of ferroptosis, cuproptosis and other forms of cell death. | Cell Commun Signal | 2023 | 37974196 | PubTator, text mining | PubMed |
| Challenges and dilemmas in pediatric hepatic Wilson's disease. | World J Hepatol | 2023 | 37970614 | PubTator, text mining | PubMed |
| Targeting cuproptosis by zinc pyrithione in triple-negative breast cancer. | iScience | 2023 | 37953954 | PubTator, text mining | PubMed |
| Cuproptosis-related gene DLAT serves as a prognostic biomarker for immunotherapy in clear cell renal cell carcinoma: multi-database and experimental verification. | Aging (Albany NY) | 2023 | 37938155 | PubTator, text mining | PubMed |
| The pleiotropic contribution of genes in dopaminergic and serotonergic pathways to addiction and related behavioral traits. | Front Psychiatry | 2023 | 37937232 | PubTator, text mining | PubMed |
| Exosomal microRNA Therapy for Non-Small-Cell Lung Cancer. | Technol Cancer Res Treat | 2023 | 37936417 | PubTator, text mining | PubMed |
| Multi-omics analysis reveals interferon-stimulated gene OAS1 as a prognostic and immunological biomarker in pan-cancer. | Front Immunol | 2023 | 37928544 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/538/papers?page=14